Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis

被引:0
作者
Cohen, MR
Reda, DJ
Clegg, DO
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Hines VA Hosp, CSPCC, Hines, IL USA
[3] Salt Lake City VAMC, Salt Lake City, UT USA
[4] Univ Utah, Salt Lake City, UT USA
关键词
psoriasis; psoriatic arthritis; seronegative arthritis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine differences in disease onset, extent, and manifestations of psoriasis among patients with active, inflammatory psoriatic arthritis (PsA), and to examine relationships that may exist between psoriasis and PsA. Methods. Baseline demographic, clinical, and laboratory data were analyzed from 221 patients enrolled in a multicenter cooperative study, and relationships between measures of psoriasis and PsA were determined. Results. Mean percentage of body surface area (BSA) affected by psoriasis was modest (12 +/- 17), and mean severity of erythema, induration, and scaling was moderate (4.9 +/- 2.1 on a 0-9 scale). Spanish Americans tended to have a higher mean percentage of BSA (18.5%) than Caucasians (11%; p = 0.067), as well as higher target lesion severity (5.55 vs 4.84; p = 0.077). Patients with psoriatic nail disease (180/221, 81%) had significantly greater number of involved distal interphalangeal (DIP) joints (p = 0.004), There were no other significant associations of skin pattern or regional involvement with PsA. Conclusion. Patients with active PsA have generally mild skin disease, and baseline relationships between psoriasis and PsA tend to be weak except for nail involvement and DIP joint activity.
引用
收藏
页码:1752 / 1756
页数:5
相关论文
共 22 条
[1]  
ABEL E, 1979, CLIN DERMATOL, V1, P150
[2]  
*AM RHEUM ASS GLOS, 1985, DICT RHEUM DIS DIAGN, V2, P51
[3]  
Biondi Oriente C, 1989, Acta Derm Venereol Suppl (Stockh), V146, P69
[4]   ARA NOMENCLATURE + CLASSIFICATION OF ARTHRITIS + RHEUMATISM ( TENTATIVE ) [J].
BLUMBERG, BS ;
BUNIM, JJ ;
ZVAIFLER, NJ ;
PIRANI, CL ;
CALKINS, E .
ARTHRITIS AND RHEUMATISM, 1964, 7 (01) :93-+
[5]  
CHRISTOPHERS E, 1989, ACTA DERM-VENEREOL, P88
[6]   Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study [J].
Clegg, DO ;
Reda, DJ ;
Mejias, E ;
Cannon, GW ;
Weisman, MH ;
Taylor, T ;
BudimanMak, E ;
Blackburn, WD ;
Vasey, FB ;
Mahowald, ML ;
Cush, JJ ;
Schumacher, HR ;
Silverman, SL ;
Alepa, FP ;
Luggen, ME ;
Cohen, MR ;
Makkena, R ;
Haakenson, CM ;
Ward, RH ;
Manaster, BJ ;
Anderson, RJ ;
Ward, JR ;
Henderson, WG .
ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2013-2020
[7]   HLA SYSTEM AND ARTHROPATHIES ASSOCIATED WITH PSORIASIS [J].
EASTMOND, CJ ;
WOODROW, JC .
ANNALS OF THE RHEUMATIC DISEASES, 1977, 36 (02) :112-120
[8]   NATURAL-HISTORY OF PSORIASIS IN 5,600 PATIENTS [J].
FARBER, EM ;
NALL, ML .
DERMATOLOGICA, 1974, 148 (01) :1-18
[9]   Disease severity measures in a population of psoriasis patients: The symptoms of psoriasis correlate with self-administered psoriasis area severity index scores [J].
Fleischer, AB ;
Feldman, SR ;
Rapp, SR ;
Reboussin, DM ;
Clark, AR ;
Rajashekhar, V .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (01) :26-29
[10]  
GLADMAN DD, 1987, Q J MED, V62, P127